160
Participants
Start Date
July 15, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2029
Venetoclax (VEN)
Venetoclax (VEN) was administered at 400mg/day on days -10 to -4.
Decitabine (DAC)
"Decitabine (DAC) was administered at 20mg/m2/day on days~-10 to -8."
Busulfan (Bu)
"Busulfan (Bu) was administered at 3.2 mg/kg/day on days~-5 to -4."
Fludarabine (Flu)
Fludarabine (Flu) was administered at 30mg/m2/day on days -5 to -2.
Fludarabine (Flu)
Fludarabine (Flu) was administered at 30mg/m2/day on days -6 to -2.
Nanfang Hospital, Southern Medical University
OTHER